2026 Chuan Qin: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	77	1784	1629	15	15	299	42521

Chuan Qin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Chuan Qin sits on this spectrum.

62 publications 807+

This scientist: 299 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Chuan Qin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Chuan Qin sits on this spectrum.

40 D-Index 157+

This scientist: 77 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Chuan Qin is affiliated with Peking Union Medical College Hospital in China, focusing primarily on research in the field of Medicine. The scientist's work spans several subfields including Infectious Diseases, Molecular Biology, Epidemiology, Neurology, and Immunology.

Their research topics cover a range of areas with particular attention to SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, and investigations into the long-term effects of COVID-19. Additionally, they have contributed to studies on viral gastroenteritis research and epidemiology, animal virus infections, Alzheimer's disease research and treatments, as well as gut microbiota and health.

Chuan Qin's recent publications demonstrate involvement in critical COVID-19 research. Notable papers include:

Development of an inactivated vaccine candidate for SARS-CoV-2, 2020, Science
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, 2020, Cell Research
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells, 2020, Cell
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice, 2020, Nature
Animal models for COVID-19, 2020, Nature

Frequent collaborators in their research include Linlin Bao, Jiangning Liu, Wei Deng, Qi Lv, and Pin Yü. This network has contributed to a substantial body of research in their shared fields.

Chuan Qin has published extensively in several scientific venues. The most common publication sources are Animal Models and Experimental Medicine, bioRxiv (Cold Spring Harbor Laboratory), Signal Transduction and Targeted Therapy, Zenodo (CERN European Organization for Nuclear Research), and Nature.

Best Publications

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.

Chuan Qin;Luoqi Zhou;Ziwei Hu;Shuoqi Zhang

5845
Citations
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Keiji Kuba;Yumiko Imai;Shuan Rao;Hong Gao

3905
Citations
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.

Shuai Xia;Meiqin Liu;Chao Wang;Wei Xu

1619
Citations
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.

Li Li Ren;Ye Ming Wang;Zhi Qiang Wu;Zi Chun Xiang

1552
Citations
Development of an inactivated vaccine candidate for SARS-CoV-2.

Qiang Gao;Linlin Bao;Haiyan Mao;Lin Wang

1525
Citations
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.

Linlin Bao;Wei Deng;Baoying Huang;Hong Gao

1443
Citations
From SARS to MERS, Thrusting Coronaviruses into the Spotlight

Zhiqi Song;Yanfeng Xu;Linlin Bao;Ling Zhang

1347
Citations
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.

Yunlong Cao;Bin Su;Xianghua Guo;Wenjie Sun

1239
Citations
Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

Li Liu;Qiang Wei;Qingqing Lin;Jun Fang

942
Citations
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.

Hui Wang;Yuntao Zhang;Baoying Huang;Wei Deng

864
Citations
Animal models for COVID-19.

César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

822
Citations
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.

Jingyun Yang;Wei Wang;Zimin Chen;Shuaiyao Lu

796
Citations
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

Jasper Fuk Woo Chan;Yanfeng Yao;Man Lung Yeung;Wei Deng

749
Citations
Immunogenicity of a DNA vaccine candidate for COVID-19.

Trevor R.F. Smith;Ami Patel;Stephanie Ramos;Dustin Elwood

740
Citations
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.

Lianpan Dai;Lianpan Dai;Tianyi Zheng;Kun Xu;Yuxuan Han

586
Citations
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.

Wei Deng;Linlin Bao;Jiangning Liu;Chong Xiao

548
Citations
Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques

Li Liu;Qiang Wei;Xavier Alvarez;Haibo Wang

516
Citations
Dual Functions of Microglia in Ischemic Stroke

Chuan Qin;Luo Qi Zhou;Xiao Tong Ma;Zi Wei Hu

510
Citations
Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease

Ling Zhang;Ying Wang;Xia Xiayu;Changhua Shi

494
Citations
Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways

Hin Chu;Jie Zhou;Bosco Ho-Yin Wong;Cun Li

473
Citations
Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China.

Xiaoquan Lai;Minghuan Wang;Chuan Qin;Li Tan

460
Citations
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China

Chuan Qin;Luoqi Zhou;Ziwei Hu;Shuoqi Zhang

344
Citations

Frequent Co-Authors

Erwan Bezard University of Bordeaux

George F. Gao Chinese Center For Disease Control and Prevention

Qin Li Peking Union Medical College Hospital

Zhiwei Chen University of Hong Kong

Qi Jin Peking Union Medical College Hospital

feng gao Duke University

Shibo Jiang Fudan University

Kwok-Yung Yuen University of Hong Kong

Yuhai Bi Chinese Academy of Sciences

Qiang Gao Beihang University

External Links

Personal website of Chuan Qin

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in combining Immunology with healthcare, exploring online nursing programs can be a great option. Many universities offer online nursing programs for non nurses, designed to help individuals without prior nursing experience transition into the field smoothly.

Accelerated options such as accelerated BSN programs for non nurses allow students to earn a Bachelor of Science in Nursing quickly, making them ideal for immunology graduates aiming to enter clinical roles.

For those seeking to start with foundational clinical experience, easy LPN programs to get into provide an accessible pathway into licensed practical nursing, offering vital patient care skills aligned with immunology knowledge.

Finally, pursuing advanced practice roles is possible through the easiest nurse practitioner program, which equips students to function at a higher clinical level and specialize in immunology-related care.